Relative renal function

Penicillamine (29) can be effective in patients with refractory RA and may delay progression of erosions, but adverse effects limit its useflilness. The most common adverse side effects for penicillamine are similar to those of parenteral gold therapy, ie, pmritic rash, protein uria, leukopenia, and thrombocytopenia. Decreased or altered taste sensation is a relatively common adverse effect for penicillamine. A monthly blood count, platelet count, and urinalysis are recommended, and also hepatic and renal function should be periodically monitored. Penicillamine is teratogenic and should not be used during pregnancy. 

Histopathological evidence of renal damage has been observed in lead-exposed workers. Renal ultrastructure and function were examined in five men with heavy occupational exposure to lead (Cramer et al. 1974). In addition, renal function was evaluated in two men from whom renal biopsies were not obtained. PbB levels ranged from 71 to 138 pg/dL. Renal function tests were normal in all except for a reduced glomerular filtration rate in one worker. Two subjects with relatively short exposure to lead (6 weeks and 8 months) and PbB levels of 89-129 pg/dL had intranuclear inclusions in the proximal tubules. Renal biopsies from workers with longer periods of lead exposure (4-20 years, PbB levels of 71-138 pg/dL) had diffuse interstitial or peritubular fibrosis. Glomeruli were normal in all subjects. 

A weak but statistically significant positive association was found between PbB level and BUN, PbB level and serum creatinine CCT was reduced with increased PbB level. The same associations were found with urinary lead level. The NAG levels in the lead-exposed workers were significantly increased over control values, and significantly increased with increasing PbB level and urinary lead level (when the data were adjusted for age). These results indicate that lead exposure resulting in relatively low PbB levels can affect renal function. 

The filtration coefficient is determined by the surface area and permeability of the filtration barrier. An increase in the filtration coefficient leads to an increase in GFR if the filtration coefficient decreases, then GFR decreases. However, this factor does not play a role in the daily regulation of GFR because its value is relatively constant under normal physiological conditions. On the other hand, chronic, uncontrolled hypertension and diabetes mellitus lead to gradual thickening of the basement membrane and therefore to a decrease in the filtration coefficient and GFR, and impaired renal function. 

The ratio (Q) of the estimated elimination rate constant or total body clearance relative to normal renal function is used to determine the dose or dosing interval alterations needed (CLfaii is the clearance with impaired renal function). 

Serum creatinine is not a good measure of renal function in elderly because muscle mass is reduced and the production of creatinine is thus reduced. Estimation of GFR based on serum creatinine is therefore not accurate enough in the elderly (Baracskay et al. 1997). Creatinine clearance should be used instead. Another possibility is measurement of cystatin C in plasma. The rate of production of cystatin C is relatively constant so it seems to be a more reliable estimation of GFR also in older adults. 

The filtered marker undergoes tubular reabsorption and secretion. The clearance of such markers depends on the relative rates of filtration, reabsorption, and secretion. Determination of renal function by these markers, typified by uric acid, is cumbersome. 

While still preliminary, this study demonstrates the feasibility of evaluating the renal status in real-time by optical modality. This continuous renal function monitoring by the optical modality represents a new and minimally invasive method to detect kidney malfunctions. In addition to using relatively harmless radiation, the simplicity and portability of the equipment make this approach compatible for use in ambulatory and critical care. However, further studies... 

Renal function impairment W th renal impairment, relative overdose might occur even with a standard dosage regimen. In patients with marked renal insufficiency (creatinine clearance less than 15 mL/min) and on hemodialysis, elimination half-lives are prolonged 2 days or less. Reduce the bolus dose and rate of infusion in patients with known or suspected renal insufficiency (see Administration and Dosage). 

Gl Gl symptoms are the most common reactions to miglitol. The incidence of diarrhea and abdominal pain tend to diminish considerably with continued treatment. Renal function impairment Plasma concentrations of miglitol in renally impaired volunteers were proportionally increased relative to the degree of renal dysfunction. Long-term clinical trials in diabetic patients with significant renal dysfunction (serum creatinine more than 2 mg/dL) have not been conducted. Treatment of these patients with miglitol is not recommended. 

Renal function impairment Relatively oliguric patients, especially those with tubular necrosis in the immediate postcadaveric transplant period, may have delayed clearance of azathioprine or its metabolites. 

Pain at the injection site is common but usually not severe. The most serious toxic effect with streptomycin is disturbance of vestibular function—vertigo and loss of balance. The frequency and severity of this disturbance are in proportion to the age of the patient, the blood levels of the drug, and the duration of administration. Vestibular dysfunction may follow a few weeks of unusually high blood levels (eg, in individuals with impaired renal function) or months of relatively low blood levels. Vestibular toxicity tends to be irreversible. Streptomycin given during pregnancy can cause deafness in the newborn and therefore is relatively contraindicated. 

Unlike renal function, hepatic maturation is generally believed to be a two-stage process with the major development completed at 4 weeks postpartum and tlie second stage completed by about 10 weeks of age. In sheep, for example, tlie activity of a number of hepatic drug-metabolizing enzymes was found to be relatively low in animals aged up to 6 months compared with adult individuals... 

The pharmacokinetics of a single oral dose of exemestane 25 mg have been studied in postmenopausal subjects with normal hepatic function (n = 9), moderately impaired hepatic function (n = 9), severely impaired hepatic function (n = 8), normal renal function (n = 6), moderately impaired renal function (n = 6), and severely impaired renal function (n = 7) (36). Exposure to exemestane was increased two- to three-fold in patients with hepatic impairment the apparent oral clearance and apparent volume of distribution of exemestane were reduced. Renal impairment was also associated with two- to three-fold increases in exposure due to reduced clearance. However, because exemestane has a relatively large safety margin, the authors considered that these effects were of no clinical significance. 

Metformin is increasingly being used in the polycystic ovarian syndrome and therefore in lactating women. In seven breastfeeding mothers taking a median dose of 1500 mg/day, the mean relative infant dose transferred in the milk was 0.28% (120). Serum metformin concentrations were very low or undetectable in infants and they appeared to be healthy. A specific warning was given for children with impaired renal function (prematurity, renal insufficiency). 

Renal function is depressed by opioids. It is believed that in humans this is chiefly due to decreased renal plasma flow. Opioids can decrease systemic blood pressure and glomerular filtration rate. In addition, opioids have been found to have an antidiuretic effect in humans. Mechanisms may involve both the CNS and peripheral sites, but the relative contributions of each are unknown. Opioids also enhance renal tubular sodium reabsorption. The role of opioid-induced changes in antidiuretic hormone (ADH) release is controversial. Ureteral and bladder tone are increased by therapeutic doses of the opioid analgesics. Increased sphincter tone may precipitate urinary retention, especially in postoperative patients. Occasionally, ureteral colic caused by a renal calculus is made worse by opioid-induced increase in ureteral tone. 

Most ACE inhibitors are eliminated primarily via the kidney. However, fosinoprilat is excreted about equally in the bile and urine (148). Biliary excretion can compensate for compromised renal function, and thus blood levels of fosinoprilat remain relatively constant in patients with varying degrees of renal impairment (150). 

---